APC and Familial adenomatous polyposis: In vivo, MBZ anti-cancer efficacy was tested in a model of familial adenomatous polyposis (FAP), using mice carrying a constitutional mutation in the Adenomatous polyposis coli (Apc) gene (Apcmin/+ mice [25].